TY - CHAP M1 - Book, Section TI - Gynecology A1 - Hamilton, Chad A1 - Stany, Michael A1 - Gregory, W. Thomas A1 - Kohn, Elise C. A2 - Brunicardi, F. Charles A2 - Andersen, Dana K. A2 - Billiar, Timothy R. A2 - Dunn, David L. A2 - Hunter, John G. A2 - Matthews, Jeffrey B. A2 - Pollock, Raphael E. PY - 2015 T2 - Schwartz's Principles of Surgery, 10e AB - Gynecologic causes of acute abdomen include pelvic inflammatory disease, tubo-ovarian abcess, ovarian torsion, ruptured ectopic pregnancy, and septic abortion. Pregnancy must be ruled out early in assessment of reproductive-age patients presenting with abdominal or pelvic pain.The general gynecology exam must incorporate the whole physical examination in order to adequately diagnosis and treat gynecologic disorders.Benign gynecologic pathologies that are encountered at the time of surgery include endometriosis, endometriomas, fibroids, and ovarian cysts.It is critical that abnormal lesions of the vulva, vagina, and cervix are biopsied for diagnosis before any treatment is planned; postmenopausal bleeding should always be investigated to rule out malignancy.Early-stage cervical cancer is managed surgically, whereas chemoradiation is preferred for stage IB2 and above.Pregnancy confers important changes to both the cardiovascular system and the coagulation cascade. Trauma in pregnancy must be managed with these changes in mind.Pelvic floor dysfunction (pelvic organ prolapse, urinary and fecal incontinence) is common; 11% of women will undergo a reconstructive surgical procedure at some point in their lives.Radical hysterectomy has unique risks of ureteral fistula and bowel dysfunction.Risk-reducing salpingo-oophorectomy (RRSO) should be considered in women with BRCA1 or BRCA2 mutations; RRSO and complete hysterectomy should be considered in women with Lynch syndrome.Optimal debulking for epithelial ovarian cancer is a critical element in patient response and survival. The preferred primary therapy for optimally debulked advanced-stage ovarian epithelial ovarian cancer is intraperitoneal chemotherapy. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/18 UR - accesssurgery.mhmedical.com/content.aspx?aid=1117753410 ER -